ID   HLY-1 eIF4E3
AC   CVCL_IN95
DR   GEO; GSM1511352
DR   GEO; GSM1511353
DR   GEO; GSM1511354
DR   GEO; GSM1511364
DR   GEO; GSM1511365
DR   GEO; GSM1511366
DR   Wikidata; Q54889872
RX   PubMed=25403230;
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Ser206Cys (c.617C>G) (p.Ser219Cys, c.656C>G) (S219C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:31837; EIF4E3.
CC   Omics: Transcriptome analysis by microarray.
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H207 ! HLY-1
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 9
//
RX   PubMed=25403230; DOI=10.1038/ncomms6413; PMCID=PMC4238046;
RA   Landon A.L., Muniandy P.A., Shetty A.C., Lehrmann E., Volpon L.,
RA   Houng S., Zhang Y.-Q., Dai B.-J., Peroutka R.J. 3rd, Mazan-Mamczarz K.,
RA   Steinhardt J., Mahurkar A., Becker K.G., Borden K.L.B.,
RA   Gartenhaus R.B.;
RT   "MNKs act as a regulatory switch for eIF4E1 and eIF4E3 driven mRNA
RT   translation in DLBCL.";
RL   Nat. Commun. 5:5413.1-5413.15(2014).
//